| 271 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Medical Oncology |
2021 |
| 272 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Medical Oncology |
2021 |
| 273 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Clinical Pathology |
2021 |
| 274 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Clinical Pathology |
2021 |
| 275 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Pediatric Oncology |
2021 |
| 276 |
Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients |
Department of Pediatric Oncology |
2021 |
| 277 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
Department of Pathology |
2021 |
| 278 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
Department of Pathology |
2021 |
| 279 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
Department of Medical Oncology |
2021 |
| 280 |
Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study |
Department of Medical Oncology |
2021 |
